Clinical trial
Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in…
NCT00407641 · Anemia Working Group Romania, Other · Withdrawn
Key facts
| NCT number | NCT00407641 |
|---|---|
| Title | Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis |
| Official title | Effects of Tinzaparin Sodium on Cardio-vascular OUtcomes and on Blood Lipids in Diabetic Patients on Chronic HEmodialysis: A Long-term, Prospective Study (The "Tinzaparin COULD HELP" Study). |
| Lead sponsor | Anemia Working Group Romania, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Hemodialysis |
| Intervention type | Drug |
| Interventions | Tinzaparin administration, Heparin administration |
| Enrollment | 0 |
| Start date | Mar 1, 2009 |
| Primary completion | Jan 1, 2015 |
| Completion | Jan 1, 2017 |
| First posted | Dec 5, 2006 |
| Last update posted | Dec 22, 2017 |
| Countries | Romania |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: